Merck & Co. Inc recalls Belsomra (suvorexant) tablets
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Failed Dissolution Specifications: potential for delayed dissolution of the dose after administration which may result in delayed release of the drug, delaying onset of sleep.
- Products
-
- Belsomra (suvorexant) tablets
- Company
- Merck & Co. Inc
- Where it was sold
-
Nationwide in the USA and PR.
Nationwide
- Units affected
- 51,320 cartons
- About this recall
- Belsomra (suvorexant) tablets, 10mg, 30 Tablets in 3 Blister Cards per Carton, Each Blister Card contains 10 Tablets, Rx only, Merck Sharp & Dohme LLC, Rahway, NJ 07065, USA, NDC 0006-0033-10 (Shellpack and Print Mat Labels), 0006-0033-30 (Carton Label)